Louis J. Arcudi Iii
United States of America
Mr. Arcudi joined the Company in 2007 as Chief Financial Officer. From 2003 to 2007, he served as Vice President of Finance and Administration and Treasurer for Peptimmune, Inc. and was responsible for all financial business and operations. Prior to joining Peptimmune, Mr. Arcudi was Senior Director of Finance and Administration at Genzyme Molecular Oncology Corporation from 2000 to 2003 and Director of Finance Business Planning and Operations International at Genzyme Corporation from 1998 to 2000. Prior to joining Genzyme, he held finance positions with increasing levels of responsibility at Cognex Corporation, Millipore Corporation, and General Motors Corporation. Mr. Arcudi received a Master of Business Administration from Bryant College and a Bachelor of Science degree in accounting and information systems from the University of Southern New Hampshire.
company developing novel nucleic acid therapeutic approaches for the treatment of certain cancers and rare diseases. Idera’s immunotherapy approach is based on the modulation of toll-like receptors (TLRs) while our third-generation antisense technology is designed to inhibit the production of disease-associated proteins by targeting RNA.